Advances in the diagnosis of human schistosomiasis

KGAD Weerakoon, GN Gobert, P Cai… - Clinical microbiology …, 2015 - Am Soc Microbiol
Schistosomiasis is a major neglected tropical disease that afflicts more than 240 million
people, including many children and young adults, in the tropics and subtropics. The …

[HTML][HTML] Non-invasive assessment of liver fibrosis

V Papastergiou, E Tsochatzis… - Annals of …, 2012 - ncbi.nlm.nih.gov
The presence and degree of hepatic fibrosis is crucial in order to make therapeutic decisions
and predict clinical outcomes. Currently, the place of liver biopsy as the standard of …

Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update

G Shiha, A Ibrahim, A Helmy, SK Sarin, M Omata… - Hepatology …, 2017 - Springer
Hepatic fibrosis is a common pathway leading to liver cirrhosis, which is the end result of any
injury to the liver. Accurate assessment of the degree of fibrosis is important clinically …

APASL consensus statements and management algorithms for hepatitis C virus infection

M Omata, T Kanda, ML Yu, O Yokosuka, SG Lim… - Hepatology …, 2012 - Springer
Abstract The Asian Pacific Association for the Study of the Liver (APASL) convened an
international working party on the “APASL Consensus Statements and Management …

Liver functional reserve estimation: state of the art and relevance for local treatments: the Eastern perspective

ST Fan - Journal of hepato-biliary-pancreatic sciences, 2010 - Springer
Liver function reserve estimation is important for selecting the appropriate patients for
hepatectomy or ablation of tumors. Many liver function tests have been devised, but the …

FibroTest for evaluating fibrosis in non-alcoholic fatty liver disease patients: a systematic review and meta-analysis

Y Vali, J Lee, J Boursier, R Spijker, J Verheij… - Journal of clinical …, 2021 - mdpi.com
(1) Background: FibroTest™ is a multi-marker panel, suggested by guidelines as one of the
surrogate markers with acceptable performance for detecting fibrosis in patients with non …

Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis

M Wang, Q Gong, J Zhang, L Chen, Z Zhang, L Lu… - Scientific reports, 2017 - nature.com
Although hepatitis B virus (HBV) infection is the leading cause of liver fibrosis (LF), the
mechanisms underlying liver fibrotic progression remain unclear. Here, we investigated the …

APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing

M Omata, T Kanda, L Wei, ML Yu, WL Chuang… - Hepatology …, 2016 - Springer
Abstract The Asian Pacific Association for the Study of the Liver (APASL) convened an
international working party on “APASL consensus statements and recommendations for …

The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non‐invasive fibrosis biomarkers: an international study of 2411 cases

G Sebastiani, L Castera, P Halfon, S Pol… - Alimentary …, 2011 - Wiley Online Library
Aliment Pharmacol Ther 2011; 34: 1202–1216 Summary Background Performance of non‐
invasive fibrosis biomarkers may be influenced by aetiology of chronic liver disease (CLD) …

EUS-guided fine-needle core liver biopsy sampling using a novel 19-gauge needle with modified 1-pass, 1 actuation wet suction technique

J Nieto, H Khaleel, Y Challita, M Jimenez… - Gastrointestinal …, 2018 - Elsevier
Background and Aims EUS-guided fine-needle core biopsy sampling is a safe and effective
technique for diagnosis of focal liver lesions. However, data are limited in its role in …